Search research articles
Contact Us
Filters
Showing results (71-80 of 116) with videos related to
Page
of 12
Sort By:
The Oncologist
|
July 21, 2021
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Daniel V Catenacci, Joseph Chao, Kei Muro, et al.
The Lancet. Oncology
|
June 17, 2023
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
Eric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, et al.
The Oncologist
|
December 21, 2019
A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases
Chongkai Wang, John Park, Ching Ouyang, et al.
JAMA Network Open
|
December 10, 2021
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer
Eric Anderson, Alexis LeVee, Sungjin Kim, et al.
World Journal of Gastrointestinal Oncology
|
March 23, 2022
Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
Lauren Midthun, Sungjin Kim, Andrew Hendifar, et al.
Cancer Chemotherapy and Pharmacology
|
January 10, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
Mihaela C Cristea, Paul Frankel, Timothy Synold, et al.
Journal for Immunotherapy of Cancer
|
February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells
Gregory P Botta, Joseph Chao, Hong Ma, et al.
World Journal of Gastrointestinal Surgery
|
October 7, 2020
Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
Sungjin Kim, Timothy P DiPeri, Michelle Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2025
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory <i>KRAS</i> G12C Colorectal Cancer
Filippo Pietrantonio, Lisa Salvatore, Taito Esaki, et al.
Annals of Surgical Oncology
|
August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial
Mustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 116) with videos related to
Sort By:
Page
of 12
The Oncologist
|
July 21, 2021
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Daniel V Catenacci, Joseph Chao, Kei Muro, et al.
The Lancet. Oncology
|
June 17, 2023
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
Eric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, et al.
The Oncologist
|
December 21, 2019
A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases
Chongkai Wang, John Park, Ching Ouyang, et al.
JAMA Network Open
|
December 10, 2021
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer
Eric Anderson, Alexis LeVee, Sungjin Kim, et al.
World Journal of Gastrointestinal Oncology
|
March 23, 2022
Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
Lauren Midthun, Sungjin Kim, Andrew Hendifar, et al.
Cancer Chemotherapy and Pharmacology
|
January 10, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity
Mihaela C Cristea, Paul Frankel, Timothy Synold, et al.
Journal for Immunotherapy of Cancer
|
February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells
Gregory P Botta, Joseph Chao, Hong Ma, et al.
World Journal of Gastrointestinal Surgery
|
October 7, 2020
Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
Sungjin Kim, Timothy P DiPeri, Michelle Guan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2025
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory <i>KRAS</i> G12C Colorectal Cancer
Filippo Pietrantonio, Lisa Salvatore, Taito Esaki, et al.
Annals of Surgical Oncology
|
August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial
Mustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Page
of 12